161 related articles for article (PubMed ID: 21864674)
1. The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nuclei.
Nalaskowski MM; Metzner A; Brehm MA; Labiadh S; Brauer H; Grabinski N; Mayr GW; Jücker M
Cell Signal; 2012 Mar; 24(3):621-8. PubMed ID: 21864674
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.
Ehm P; Nalaskowski MM; Wundenberg T; Jücker M
Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.
Nalaskowski MM; Ehm P; Rehbach C; Nelson N; Täger M; Modest K; Jücker M
Cell Signal; 2018 Sep; 49():87-94. PubMed ID: 29852247
[TBL] [Abstract][Full Text] [Related]
4. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
[TBL] [Abstract][Full Text] [Related]
5. The role of SHIP1 in T-lymphocyte life and death.
Gloire G; Erneux C; Piette J
Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
[TBL] [Abstract][Full Text] [Related]
6. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
Elong Edimo W; Vanderwinden JM; Erneux C
Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
[TBL] [Abstract][Full Text] [Related]
7. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
8. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
[TBL] [Abstract][Full Text] [Related]
9. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
Waddell GL; Drew EE; Rupp HP; Hansen SD
J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
[TBL] [Abstract][Full Text] [Related]
11. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
Isnardi I; Bruhns P; Bismuth G; Fridman WH; Daëron M
Immunol Lett; 2006 Apr; 104(1-2):156-65. PubMed ID: 16406061
[TBL] [Abstract][Full Text] [Related]
12. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
Edimo WE; Janssens V; Waelkens E; Erneux C
Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
14. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
[TBL] [Abstract][Full Text] [Related]
15. Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D.
Metzner A; Precht C; Fehse B; Fiedler W; Stocking C; Günther A; Mayr GW; Jücker M
Gene Ther; 2009 Apr; 16(4):570-3. PubMed ID: 19148132
[TBL] [Abstract][Full Text] [Related]
16. The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-α interaction.
Mukherjee O; Weingarten L; Padberg I; Pracht C; Sinha R; Hochdörfer T; Kuppig S; Backofen R; Reth M; Huber M
Biochim Biophys Acta; 2012 Feb; 1823(2):206-14. PubMed ID: 22182704
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.
Séverin S; Gratacap MP; Lenain N; Alvarez L; Hollande E; Penninger JM; Gachet C; Plantavid M; Payrastre B
J Clin Invest; 2007 Apr; 117(4):944-52. PubMed ID: 17347685
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
[TBL] [Abstract][Full Text] [Related]
19. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).
Zhang J; Ravichandran KS; Garrison JC
J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657
[TBL] [Abstract][Full Text] [Related]
20. SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase.
Tomlinson MG; Heath VL; Turck CW; Watson SP; Weiss A
J Biol Chem; 2004 Dec; 279(53):55089-96. PubMed ID: 15492005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
